Literature DB >> 20462343

From molecular mechanisms of cardiac development to genetic substrate of congenital heart diseases.

Antonella Cecchetto1, Alessandra Rampazzo, Annalisa Angelini, Lucia Dal Bianco, Massimo Padalino, Giovanni Stellin, Luciano Daliento.   

Abstract

Congenital heart disease is one of the most important chapters in medicine because its incidence is increasing and nowadays it is close to 1.2%. Most congenital heart disorders are the result of defects during embryogenesis, which implies that they are due to alterations in genes involved in cardiac development. This review summarizes current knowledge regarding the molecular mechanisms involved in cardiac development in order to clarify the genetic basis of congenital heart disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20462343     DOI: 10.2217/fca.10.10

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  10 in total

1.  GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect.

Authors:  Dong Wei; Han Bao; Ning Zhou; Gui-Fen Zheng; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2012-09-09       Impact factor: 1.655

2.  Prevalence and spectrum of PITX2c mutations associated with congenital heart disease.

Authors:  Juan Wang; Yuan-Feng Xin; Wen-Jun Xu; Zhong-Min Liu; Xing-Biao Qiu; Xin-Kai Qu; Lei Xu; Xin Li; Yi-Qing Yang
Journal:  DNA Cell Biol       Date:  2013-10-01       Impact factor: 3.311

3.  Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach.

Authors:  Danning He; Zhi-Ping Liu; Luonan Chen
Journal:  BMC Genomics       Date:  2011-12-02       Impact factor: 3.969

4.  Stage-specific regulation of signalling pathways to differentiate pluripotent stem cells to cardiomyocytes with ventricular lineage.

Authors:  Ramakanth Satthenapalli; Scott Lee; Jayanthi Bellae Papannarao; Timothy A Hore; Akash Chakraborty; Peter P Jones; Regis R Lamberts; Rajesh Katare
Journal:  Stem Cell Res Ther       Date:  2022-05-06       Impact factor: 6.832

5.  Functional study of DAND5 variant in patients with Congenital Heart Disease and laterality defects.

Authors:  Fernando Cristo; José M Inácio; Salomé de Almeida; Patrícia Mendes; Duarte Saraiva Martins; José Maio; Rui Anjos; José A Belo
Journal:  BMC Med Genet       Date:  2017-07-24       Impact factor: 2.103

Review 6.  Associations of GATA4 genetic mutations with the risk of congenital heart disease: A meta-analysis.

Authors:  Yanwei Zhang; Feng Ai; Jiayong Zheng; Bangtian Peng
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

Review 7.  Insights into role of microRNAs in cardiac development, cardiac diseases, and developing novel therapies.

Authors:  Maedeh Arabian; Fatemeh Mirzadeh Azad; Majid Maleki; Mahshid Malakootian
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

8.  GATA5 loss-of-function mutations underlie tetralogy of fallot.

Authors:  Dong Wei; Han Bao; Xing-Yuan Liu; Ning Zhou; Qian Wang; Ruo-Gu Li; Ying-Jia Xu; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2012-12-10       Impact factor: 3.738

9.  PITX2c loss-of-function mutations responsible for congenital atrial septal defects.

Authors:  Fang Yuan; Lan Zhao; Juan Wang; Wei Zhang; Xin Li; Xing-Biao Qiu; Ruo-Gu Li; Ying-Jia Xu; Lei Xu; Xing-Kai Qu; Wei-Yi Fang; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2013-08-22       Impact factor: 3.738

10.  Islet-1 may function as an assistant factor for histone acetylation and regulation of cardiac development-related transcription factor Mef2c expression.

Authors:  Zhongsu Yu; Juanjuan Kong; Bo Pan; Huichao Sun; Tiewei Lv; Jing Zhu; Guoying Huang; Jie Tian
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.